Journals / Turkish Journal of Gastroenterology / 2021 / Cilt: 32 - Sayı: 7

Are Pattern Recognition Receptors Associated with Hepatocellular Carcinoma?

Pages
593–599
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: We think that increased bacterial translocation in cirrhotic patients may contribute to HCC development by causing chronic inflammation, especially in patients with TLR 1 (rs5743551) polymorphism.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Hepatocellular carcinoma (HCC) is one of the important causes of mortality due to malignancy.
📊
Key Findings & Data:In this study, we planned to examine the role of TLR1 (rs4833095, rs5743551) and nucleotide-binding oligomerization domain (NOD2) (rs2066844, rs2066845, rs2066847) polymorphisms in the development of HCC and their effects on the clinical presentation of HCC patients.
💡
Conclusion & Impact:Conclusion: We think that increased bacterial translocation in cirrhotic patients may contribute to HCC development by causing chronic inflammation, especially in patients with TLR 1 (rs5743551) polymorphism.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Background: Hepatocellular carcinoma (HCC) is one of the important causes of mortality due to malignancy. Toll-like receptors (TLRs) are very important in liver pathophysiology in terms of their roles in the innate immune system, such as the regulation of inflammation, wound healing, stimulation of adaptive immune responses, promotion of epithelial regeneration, and carcinogenesis. In this study, we planned to examine the role of TLR1 (rs4833095, rs5743551) and nucleotide-binding oligomerization domain (NOD2) (rs2066844, rs2066845, rs2066847) polymorphisms in the development of HCC and their effects on the clinical presentation of HCC patients. Methods: Our study was designed prospectively. Cirrhotic and HCC patients who were followed up in our clinic between January 2015 and September 2018 were included in the study. Sex, age, cirrhosis etiology, Child–Pugh class, and MELD scores were recorded. TLR1 and NOD2 polymorphisms were studied by the PCR method. Results: HCC developed in 88 (31.4%) of the 280 patients who were followed up, either during the recruitment phase of our study or during the follow-up. The mean follow-up time of our patient group was 17.04 ± 11.72 months, and the mean follow-up time of HCC patients was 12.09 ± 10.26 months. TLR1 (rs5743551) polymorphism was associated with HCC development (P = .003). TLR1 (rs5743551) and NOD2 (rs2066844) polymorphisms were associated with the development of spontaneous bacterial peritonitis (SBP) in the HCC patient group (P = .013 and P = .021, respectively). Conclusion: We think that increased bacterial translocation in cirrhotic patients may contribute to HCC development by causing chronic inflammation, especially in patients with TLR 1 (rs5743551) polymorphism.

🔖

Cite This Article

DERTLİ, R., AŞIL, M., BIYIK, M., KARAKARCAYILDIZ, A., KESKİN, M., KAYAR, Y., BAŞDEMİRCİ, M., ATASEVEN, H. (2021). Are Pattern Recognition Receptors Associated with Hepatocellular Carcinoma?. Turkish Journal of Gastroenterology, Cilt: 32 - Sayı: 7, 593–599. https://ajindex.com/articles/408659

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015
  2. 65(2):87-108. [CrossRef] 2. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol. 2009
  3. 27(9):1485-1491. [CrossRef] 3. Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015
  4. 61(1):191- 199. [CrossRef] 4. Mehmet A, Dertli R. Serum soluble TWEAK concentration is decreased in patients with hepatocellular cancer and low blood levels of sTWEAK are associated with poor survival. Int J Hematol Oncol
  5. 28(4):118-126. 5. Zahran AM, Zahran ZAM, El-Badawy O, et al. Prognostic impact of toll-like receptors 2 and 4 expression on monocytes in Egyptian patients with hepatocellular carcinoma. Immunol Res. 2019
  6. 67(2- 3):157-165. [CrossRef] 6. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001
  7. 411(6837):603-606. [CrossRef] 7. Harputluoglu MM, Dertli R, Otlu B, et al. Nucleotide-binding oligomerization domain-containing protein 2 variants in patients with spontaneous bacterial peritonitis. Dig Dis Sci. 2016
  8. 61(6):1545- 1552. [CrossRef] 8. Fritz JH, Ferrero RL, Philpott DJ, Girardin SE. Nod-like proteins in immunity, inflammation and disease. Nat Immunol. 2006
  9. 7(12):1250- 1257. [CrossRef] 9. Ekman AK, Cardell LO. The expression and function of Nod‐like receptors in neutrophils. Immunology. 2010
  10. 130(1):55-63. [CrossRef] 10. Henao-Mejia J, Elinav E, Thaiss CA, Licona-Limon P, Flavell RA. Role of the intestinal microbiome in liver disease. J Autoimmun. 2013
  11. [CrossRef] 11. Zhu Q, Zou L, Jagavelu K, et al. Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice. J Hepatol. 2012
  12. 56(4):893-899. [CrossRef] 12. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010
  13. 11(5):373-384. [CrossRef] 13. Moynagh PN. TLR signalling and activation of IRFs: revisiting old friends from the NF-κB pathway. Trends Immunol. 2005
  14. 26(9):469- 476. [CrossRef] 14. O’Neill LA, Bryant CE, Doyle SL. Therapeutic targeting of toll-like receptors for infectious and inflammatory diseases and cancer. Pharmacol Rev. 2009
  15. 61(2):177-197. [CrossRef] 15. Huang YH, Wu JC, Chen CH, et al. Comparison of recu